XML 51 R17.htm IDEA: XBRL DOCUMENT v2.4.0.6
DERIVATIVE LIABILITIES
12 Months Ended
Dec. 31, 2012
DERIVATIVE LIABILITIES [Abstract]  
DERIVATIVE LIABILITIES
NOTE 11 –DERIVATIVE LIABILITIES
 
The Company's warrants, preferred stock, and its Convertible 8% Senior Secured Notes issued in 2010, 2009, and 2008 have reset provisions to the exercise price and conversion price if the Company issues equity or notes at a price less than the exercise price set forth in such warrants and notes. This ratchet provision results in a derivative liability in our financial statements.

Our derivative liabilities decreased from $11,031,432 at December 31, 2011 to $8,025,381 at December 31, 2012.  For the year ended December 31, 2012, the change in fair value was a negative $1,514,156. The change in fair value during the year ended December 31, 2011 resulted in a gain of $3,396,298
  
The following tabular presentation reflects the components of derivative financial instruments on the Company's balance sheet at December 31, 2012 and December 31, 2011:

 
12/31/2012
 
 
12/31/2011
 
Common stock warrants
 
$
6,626,255
 
 
$
8,829,215
 
Embedded conversion features for convertible debt or preferred shares
 
 
1,399,126
 
 
 
2,202,217
 
 
 
 
 
 
 
 
 
Total
 
$
8,025,381
 
 
$
11,031,432
 
 
 
 
 
 
 
 
 
Beginning balance
 
$
11,031,432
 
 
$
13,528,355
 
Bifurcated amount
 
 
-
 
 
 
3,386,697
 
Change in derivative liability valuation
 
 
1,514,156
 
 
 
(3,396,298
)
Change in derivative liability - settlements
 
 
(4,520,207
)
 
 
(2,487,322
)
 
 
 
 
 
 
 
 
Total
 
$
8,025,381
 
 
$
11,031,432
 
 
During 2012, the Company issued 689,087 shares of common stock as a result of the exercise of warrants both on a cash and cashless basis. The impact of these issuances to the related embedded derivative liabilities was a decrease to the derivative liability and increase to additional paid in capital for $1,021,913 on the exercise dates. Also during 2012, the Company issued 1,658,979 shares of common stock as a result of the conversion of the remaining 2008 and 2010 notes payable, including accrued interest. The impact of these conversions to the related embedded derivative liabilities was a decrease to the derivative liability and increase to additional paid in capital for $48,619 on the conversion dates. Finally, the Company issued 5,493,912 shares of common stock as a result of the conversion of Series I Preferred Stock and accrued dividends. The impact of these conversions to the related embedded derivative liabilities was a decrease to the derivative liability and increase to additional paid in capital for $3,449,675 on the conversion dates.

For the year ended December 31, 2011, the Company issued 56,489 shares of common stock as a result of the exercise of warrants for cash. The impact on paid in capital was an increase of $3,350 and the change to the derivative liability was $34,388. Also during 2011, the Company issued 5,294,029 shares of common stock as a result of the conversion of the 2008, 2009 and 2010 notes payable, including accrued interest. The impact on paid in capital was an increase of $5,343,321 and a change to the derivative liability of $2,410,865. Finally, the Company issued 126,440 shares of common stock as a result of the conversion of Series I Preferred Stock and accrued dividends. The impact on paid in capital was an increase of $126,434 and the change to the derivative liability as a result of the settlement was $42,069.